About


Overview of the Team
Investigators

        Doug Angus         Melissa Brouwers         Martin Eccles         Jill Francis         Gaston Godin         Ian Graham         Jeremy Grimshaw         Steve Hanna         Margaret Harrison         Louise Lemyre         Jo Logan         Merrick Zwarenstein
New Investigators

        Onil Bhattacharyya         Michelle Driedger         France Légaré         Linda Li         Rosemary Martino         Marie-Pascale Pomey
Students

        Shawn Bugden         Gaby Doumit         Sandy Dunn         Jennifer Eyvindson         Noah Ivers         Annie Leblanc         Justin Presseau         Micheal G. Wilson
Collaborators

        Jacqueline Tetroe
Team Coordinator

        Vanessa Lybanon
   


Melissa Brouwers
Melissa Brouwers c.v.

  • Associate Professor (Part-Time), Clinical Epidemiology and Biostatistics, Faculty of Health Sciences, McMaster University
  • Director, Program in Evidence-based Care, Cancer Care Ontario


Research Interests

  • The development, dissemination, implementation and evaluation of evidence-based decisions products such as clinical practice guidelines, standards, quality indicators, etc.
  • Decision-making, knowledge translation and/or brokering, and behaviour change particularly as it relates to health communication.
 Melissa Brouwers

Biography

Dr. Brouwers is the Director of the Program in Evidence-based Care, Cancer Care Ontario and an Associate Professor (PT) in the Department of Clinical Epidemiology and Biostatistics.  She holds a BSc in psychology from the University of Toronto and an M.A. and PhD. in psychology from the University of Western Ontario. Dr Brouwers is an active and leading member of the Canadian Strategy for Cancer Control (CSCC) and the principle lead of the Health Technology Utilization Guidelines of Ontario (Health TUGO), a collaboration between the MOHLTC Medical Advisory Secretariat and McMaster University.

 

<Return to top>

Major Research Activities

Research activity Funding
Development of utilization guidelines for health technologies in Ontario 2005-2007 Ontario Ministry of Health and Long-Term Care
AGREE next steps: continuous quality improvement in the assessment of clinical practice guidelines 2005-2007 CIHR
Knowledge development, exchange and uptake: a new roadmap from evidence to practice in oncology 2004-2006 CIHR
Program in Evidence-based Care, Cancer Care Ontario 2006-2007 Ministry of Health and Long-term Care through Cancer Care Ontario
The Life Cycle of Evidence in Health Care 2006-2008
Canada PRIME: Process modelling and Implementation: selecting a theoretical basis to change clinical practice 2004-2007 CIHR
Building capacity: Development of a transdisciplinary team for improving the quality of health care 2003-2008 CIHR


<Return to top>

Selected Publications

  • Evans WK, Graham ID, Cameron D, Mackay JA, Brouwers M. Practitioner Feedback on Lung Cancer Practice Guidelines in Ontario. J Thorac Oncol. 2006;(1):10-8.


  • The Improved Clinical Effectiveness through Behavioural Research Group (ICEBeRG): Eccles M, Angus D, Brouwers M, Driedger M, Francis J, Godin G, Graham I, Grimshaw J, Hanna S, Harrison MG, Legare F, Lemyre L, Logan J, Martino R, Pomey M-P, Tetroe J. Designing theoretically-informed implementation interventions. Implementation Science. 2006;1:4(23 Feb 2006).


  • Johnston M, Elit J, Brouwers M, Fung Kee Fung M, Browman G, Graham ID, on behalf of the Gynecologic Oncology Group Canada and the Strategy for Cancer Control Clinical Practice Guidelines Action Group. Promoting best gynecologic oncology practice: A focus group addressing the Potential Role for the Society of Gynecologic Oncologists of Canada. Current Oncology (Accepted for Publication)


  • Brouwers MC, Kono N, van Greevenbroek MM, van der Kallen CJ, Lusis AJ, deBruin TW, Cantor RM. Longitudinal differences in familial combined hyperlipidemia quantitative trait loci. Arterioscler Thromb Vasc Biol. 2006 Jun;26(6):e118-9.


  • Dingle BH, Rumble RB, Brouwers MC; Cancer Care Ontario's Program in Evidence-Based Care's Gastrointestinal Cancer Disease Site Group. The role of gemcitabine in the treatment of cholangiocarcinoma and gallbladder cancer: a systematic review. Can J Gastroenterol. 2005 Dec;19(12):711-6.


  • Brouwers MC, Johnston ME, Charette ML, Hanna SE, Jadad AR, Browman GP. Evaluating the role of quality assessment of primary studies in systematic reviews of cancer practice guidelines. BMC Med Res Methodol. 2005 Feb 16;5(1):8.


  • Brouwers MC, Graham ID, Hanna SE, Cameron DA, Browman GP. Clinicians' assessments of practice guidelines in oncology: the CAPGO survey. Int J Technol Assess Health Care. 2004 Fall;20(4):421-6.


  • Figueredo A, Charette ML, Maroun J, Brouwers MC, Zuraw L. Adjuvant therapy for stage II colon cancer: a systematic review from the Cancer Care Ontario Program in evidence-based care's gastrointestinal cancer disease site group. J Clin Oncol. 2004 Aug 15;22(16):3395-407. Epub 2004 Jun 15.


  • de Bruin TW, Georgieva AM, Brouwers MC, Heitink MV, van der Kallen CJ, van Greevenbroek MM. Radiological evidence of nonalcoholic fatty liver disease in familial combined hyperlipidemia. Am J Med. 2004 Jun 15;116(12):847-9.


  • Johnston ME, Brouwers MC, Browman GP. Keeping cancer guidelines current: results of a comprehensive prospective literature monitoring strategy for twenty clinical practice guidelines. Int J Technol Assess Health Care. 2003 Fall;19(4):646-55.


  • Georgieva AM, van Greevenbroek MM, Krauss RM, Brouwers MC, Vermeulen VM, Robertus-Teunissen MG, van der Kallen CJ, de Bruin TW. Subclasses of low-density lipoprotein and very low-density lipoprotein in familial combined hyperlipidemia: relationship to multiple lipoprotein phenotype. Arterioscler Thromb Vasc Biol. 2004 Apr;24(4):744-9.

  • Brouwers MC, Chambers A, Perry J, Can surveying practitioners about their practices help identify priority clinical practice guideline topics? BMC Health Services Research 2003;3:23.


  • Brouwers MC, Chambers A, Perry J; Neuro-oncology Disease Site Group. Can surveying practitioners about their practices help identify priority clinical practice guideline topics? BMC Health Serv Res. 2003 Dec 19;3(1):23



  • Pater JL, Browman GP, Brouwers MC, Nefsky MF, Evans WK, Cowan DH. Funding new cancer drugs in Ontario: closing the loop in the practice guidelines development cycle. J Clin Oncol. 2001 Jul 15;19(14):3392-6.


  • Haynes RB, Montague P, Oliver T, McKibbon KA, Brouwers MC, Kanani R. Interventions for helping patients to follow prescriptions for medications. Cochrane Database Syst Rev. 2000;(2):CD000011.


  • Brouwers MC, Browman GP. Development of clinical practice guidelines: surgical perspective. World J Surg. 1999 Dec;23(12):1236-41.


  • Brouwers MC, Haynes RB, Jadad AR, Hayward RS, Padunsky JA, Yang JL. Evidence-based health care and the Cochrane Collaboration. Clin Perform Qual Health Care. 1997 Oct-Dec;5(4):195-201.




    •
<Return to top>

Funded by:

Click to access the CIHR website              Click to access the Ontario Ministry of Health website




Design/Content by Nicole Robinson & Justin Presseau
2006 - All Rights Reserved